4.6 Review

Heme oxygenase-1: from biology to therapeutic potential

期刊

TRENDS IN MOLECULAR MEDICINE
卷 15, 期 2, 页码 50-58

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2008.12.004

关键词

-

资金

  1. 'Fundacao para Ciencia e Tecnologia', Portugal [POCTI/BIA-BCM/56829/2004, POCTI/SAU-MNO/56066/2004, POCTI/SAU-MNO/56066/2007]
  2. European Commission's Sixth Framework Programme, Xenome [LSHB-CT-2006-037377]
  3. GEMI fund (Linde Health care)
  4. National Institutes of Health [HL77721, HL58688]
  5. Julie Henry Fund of the Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA

向作者/读者索取更多资源

Heme oxygenase-1 (HO-1) is a stress-responsive enzyme that catabolizes free heme into carbon monoxide, iron (which induces the expression of heavy-chain ferritin, an iron-sequestering protein) and biliverdin (which is converted to bilirubin by biliverdin reductase). Over the past few years it has become apparent that these 'arms' of the HO-1 system can act protectively in a variety of experimental models of disease; there is also evidence that HO-1 and bilirubin have protective actions in humans. Here, we present a model for the beneficial actions of the products of heme degradation, and we discuss the potential clinical applications of enhancing the HO-1 system.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据